Work continues on the $250M expansion of our Norton, Massachusetts #biomanufacturing facility. To mark our exciting progress, Alnylam employees and representatives of our construction and engineering partners Commodore Builders and CRB recently signed their names to a structural beam that was lifted into position.

Our Norton facility is at the center of Alnylam's global RNAi therapeutics manufacturing operations. It's also where we're continuing to innovate in the manufacturing of #RNAi therapeutics by building out new capacity and siRNA enzymatic ligation capabilities. Learn more about what's going on in Norton and how we make our medicines: https://lnkd.in/gUhMi4eh